Vishay positions itself as a critical supplier of foundational semiconductor and passive components essential for power management and signal processing across diverse end markets. The company maintains competitive advantages through extensive product portfolio, global manufacturing footprint, and deep customer relationships in mission-critical applications, though faces headwinds from commodity pricing pressures and inventory normalization.
Cyborg Score Rationale
Vishay demonstrates steady market position with diversified end-market exposure, but faces near-term earnings pressures evidenced by Q4 2025 earnings miss (EPS $0.01 vs. forecasts) despite revenue beat. Recent analyst downgrades and concerns over convertible notes dilution signal execution challenges and balance sheet stress that offset the strength of its essential component supply position.
Top Insights
Q4 2025 reported significant EPS miss ($0.01 actual vs. forecast expectations) despite revenue beat at $801M, indicating margin compression and operational challenges
Stock trading near 52-week highs ($22.00) with analyst consensus downgraded to neutral, showing mixed institutional sentiment despite revenue recovery
Q1 2026 guidance projects $800-830M revenue with 19.9% gross margin, suggesting modest demand recovery but continued profitability pressure
Convertible notes issued and refinancing risks identified by analysts, creating potential shareholder dilution and limiting financial flexibility for strategic investments
Named Competitors
Discrete Semiconductors & Power Management — Broader semiconductor portfolio competitor in power and signal management
Passive Components — Leading passive component supplier globally with stronger margin profile
Discretes & Analog — Diversified analog and mixed-signal semiconductor competitor
Recent Developments
(February 2026) Vishay Intertechnology announces 2030 Convertible Notes with refinancing risks and potential shareholder dilution concerns raised by analysts
(February 2026) Q4 2025 earnings reveal significant EPS miss despite revenue beat; BofA downgrades price target from $16 to $15